The Life Insurance Market
A treatment for cervical cancer has saved thousands of women’s lives and in turn meant that they didn’t need to claim on their critical illness cover as early as they may have done in the past.
This comes after a study found that the use of cisplatin alongside radiotherapy reduced the likelihood of death by a quarter (23 per cent), compared to radiotherapy alone.
The drug was known to improve survival chances, but this study by researchers at the University of Leicester is the first time it has been proven how effective it can be in the long-term.
However, as with other treatments for the disease, the use of cisplatin alongside radiotherapy is not a guaranteed cure, so women at risk of cervical cancer should still consider critical illness cover.
Post your own comment